MK2637
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for MK2637, covering 2015-06-24 to 2015-06-24. Get the full timeline:
Most recent: Clinical Trial Update: Study of the Effect of Single Doses of MK2637 and Dextromethorphan on Cerebral Cortex Excitability (2637-008) [Phase 1]